arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2403.00716q-bio.QM
收藏

少样本基因选择:用于乳腺癌亚型分类的PAM50基因子集

Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification

Leandro Y. S. Okimoto, Rayol Mendonca-Neto, Fabíola G. Nakamura, Eduardo F. Nakamura, David Fenyö, Claudio T. Silva

AI总结:

针对PAM50基因数量多、成本高的问题,提出少样本基因选择方法并用SVM评估随机子集,发现36个基因可达到相当或更优的乳腺癌亚型分类性能。

摘要:

背景:近年来,研究人员在理解乳腺癌异质性及其各种亚型方面取得了重大进展。然而,当今可用的大量基因组和蛋白质组数据需要高效的框架、手段和计算工具才能进行有意义的分析。尽管PAM50基因特征作为一种预后工具取得了成功,但它对许多基因的依赖在成本和复杂性方面带来了挑战。因此,需要更高效的方法,利用缩减的基因集准确分类乳腺癌亚型。结果:本研究探索了利用源自PAM50基因特征的缩减基因集实现精确乳腺癌亚型分类的潜力。通过采用“少样本基因选择”方法,我们从PAM50中随机选择较小的子集,并使用评价指标和线性模型(具体为支持向量机(SVM)分类器)评估其性能。此外,我们旨在评估更紧凑的基因集能否在简化分类过程的同时保持性能。我们的研究结果表明,某些缩减的基因子集可以表现出与完整PAM50基因特征相当或更优的性能。结论:所识别出的包含36个基因的基因子集,有望为乳腺癌研究和临床环境中开发更具成本效益且更精简的诊断工具作出贡献。

英文摘要:

Background: In recent years, researchers have made significant strides in understanding the heterogeneity of breast cancer and its various subtypes. However, the wealth of genomic and proteomic data available today necessitates efficient frameworks, instruments, and computational tools for meaningful analysis. Despite its success as a prognostic tool, the PAM50 gene signature's reliance on many genes presents challenges in terms of cost and complexity. Consequently, there is a need for more efficient methods to classify breast cancer subtypes using a reduced gene set accurately. Results: This study explores the potential of achieving precise breast cancer subtype categorization using a reduced gene set derived from the PAM50 gene signature. By employing a "Few-Shot Genes Selection" method, we randomly select smaller subsets from PAM50 and evaluate their performance using metrics and a linear model, specifically the Support Vector Machine (SVM) classifier. In addition, we aim to assess whether a more compact gene set can maintain performance while simplifying the classification process. Our findings demonstrate that certain reduced gene subsets can perform comparable or superior to the full PAM50 gene signature. Conclusions: The identified gene subsets, with 36 genes, have the potential to contribute to the development of more cost-effective and streamlined diagnostic tools in breast cancer research and clinical settings.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑